成人脓毒症

When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

最后审阅: 5 Oct 2024
最后更新: 12 Jun 2024
12 Jun 2024

NICE 指导建议使用 NEWS2 改善成人脓毒症的风险评估和管理

在对证据进行审查后,英国国家卫生与临床优化研究所(National Institute for Health and Care Excellence, NICE)更新了 16 岁或以上患者脓毒症管理指导。

NICE 建议:

  • 使用 NEWS2(早期预警评分)来评估医院、急性精神卫生机构和救护车中的疑似脓毒症患者。NICE 继续建议在紧急情况下使用 NICE 高风险标准(而不是 NEWS2)对妊娠或近期刚妊娠的患者以及社区或监护机构中的患者进行风险分层。

  • 每次进行新观察或者当病情恶化或出现意外变化时,应重新评估患者的风险等级

  • 如果患者病情没有改善,在采取任何干预措施(抗生素/液体复苏/给氧)后 1 小时内,召集一名高级临床决策者(如英国的 ST3 级医生)亲自到场。

  • 应认识到,如果某单项参数在 NEWS2 评分中占到 3 分,就意味着器官功能障碍和病情进一步恶化的风险增加,这是一个重要的警示信号。

NEWS2 已在英格兰大多数国家医疗服务体系的紧急医疗机构、急诊科、救护车服务和精神卫生机构中使用,因此这些建议旨在进一步提高脓毒症所致急性病识别和应对措施的一致性。

查看诊断:诊断建议

查看治疗:治疗路径

更新原始来源

小结

定义

病史和体格检查

关键诊断因素

  • 危险因素
  • 特定感染源的体征
  • 较高的早期预警得分(例如,NEWS2 ≥5 分)
  • 呼吸急促(NEWS2)
  • 体温偏高或偏低,偶有寒战(NEWS2)
  • 心动过速(NEWS2)
  • 急性意识状态改变(NEWS2)
  • 低血氧饱和度(NEWS2)
  • 低血压(NEWS2)
  • 少尿
  • 毛细血管再充盈不良、皮肤斑驳或面色苍白
  • 紫绀
完整详情

其他诊断因素

  • 周身不适/昏睡
  • 恶心/呕吐/腹泻
  • 暴发性紫癜
  • 肠梗阻
  • 黄疸
完整详情

危险因素

  • 年龄>65 岁
  • 免疫功能受损
  • 留置输液管或导管
  • 近期手术或其他侵入性操作
  • 血液透析
  • 糖尿病
  • 静脉注射药物滥用
  • 酒精依赖
  • 妊娠
  • 皮肤完整性破坏
  • 城市居民
  • 肺部疾病
  • 男性
  • 非白人血统
  • 冬季
完整详情

诊断性检查

首要检查

  • 血培养
  • 血清乳酸
  • 每小时尿量
  • 全血细胞计数
  • 尿素和电解质(包括肌酐)
  • 血清葡萄糖
  • C 反应蛋白
  • 血清原降钙素
  • 凝血筛查
  • 肝功能检测
  • 血气
  • 心电图(ECG)
完整详情

需考虑的检查

  • 尿液分析
  • 胸部 X 线检查
  • 多来源样本培养
  • 腰椎穿刺:
  • 计算机断层扫描
  • 超声
  • 尿抗原检测
  • 病毒拭子
  • HIV 筛查
  • 超声心动图
完整详情

治疗流程

初步治疗

住院:高度怀疑脓毒症,细菌感染来源未知或不明

社区中:高度怀疑脓毒症,确诊或高度怀疑细菌感染

急症处理

住院:高度怀疑脓毒症,细菌感染源明确

撰稿人

专家顾问

Alexander Alexiou, MB, BS, BSc, DCH, FRCEM, Dip IMC RCSEd

Emergency Medicine Consultant

Physician Response Unit Consultant

Barts Health NHS Trust

London’s Air Ambulance

Royal London Hospital

London

UK

利益声明

AA declares that he has no competing interests.

Clovis Rau, MBBS, BSc, FRCEM, DipIMC

Specialty Registrar Emergency Medicine (ST6)

Barnet Hospital

Royal Free NHS Foundation Trust

London

UK

利益声明

CR declares that he has no competing interests.

Acknowledgements

BMJ Best Practice would like to gratefully acknowledge the previous team of expert contributors, whose work has been retained in parts of the content:

Ron Daniels MBChB, FRCA

Chief Executive

United Kingdom Sepsis Trust

Chief Executive

Global Sepsis Alliance

Programme Director

Survive Sepsis

Consultant in Critical Care and Anaesthesia

Heart of England NHS Foundation Trust

Birmingham

UK

Matt Inada-Kim MBBS, FRCP

Consultant Acute Physician & Sepsis Lead

Department of Acute Medicine

Royal Hampshire County Hospital

Hampshire Hospitals NHS Foundation Trust

Winchester

UK

Aamir Saifuddin BMBCh, BA, MRCP, AFFMLM

Specialty Registrar in Gastroenterology and General Medicine

Maidstone and Tunbridge Wells NHS Trust

UK

Tim Nutbeam MSc, Dip IMC FRCEM

Consultant in Emergency Medicine

Clinical Academic

University of Plymouth

Lead Doctor

Devon Air Ambulance Trust

Derriford Hospital

Plymouth

UK

Edward Berry MBChB, MCEM

Specialty Registrar in Emergency Medicine

Derriford Hospital

Plymouth

UK

利益声明

RD has received payment for consultancy on sepsis from Kimal Plc, manufacturers of vascular access devices, from the Northumbria Partnership, a patient safety collaborative, and, where annual leave or other income was compromised in fulfilling his charity duties, from the UK Sepsis Trust. RD has received sponsorship to attend and speak at one meeting from Abbott Diagnostics. He is CEO of the UK Sepsis Trust and Global Sepsis Alliance, and advises HM Government, the World Health Organization, and NHS England on sepsis. Each of these positions demands that he express opinion on strategies around the recognition and management of sepsis. MIK is a national clinical advisor on sepsis to NHS England and a national clinical advisor on deterioration to NHS Improvement. He was reimbursed for a slide set by Relias Learning. AS is the clinical fellow to the National Medical Director at NHS Improvement. AS has been sponsored on two occasions by Dr Falk Pharma UK to attend specialist gastroenterology conferences abroad; there was no contractual obligation to disseminate product information. TN is a clinical adviser to the UK Sepsis Trust. EB declares that he has no competing interests.

同行评议者

Matt Inada-Kim, MBBS, FRCP

Consultant Acute Physician & Sepsis Lead

Department of Acute Medicine

Royal Hampshire County Hospital

Hampshire Hospitals NHS Foundation Trust

Winchester

UK

利益声明

MIK is a national clinical advisor on sepsis to NHS England and a national clinical advisor on deterioration to NHS Improvement. He was reimbursed for a slide set by Relias Learning.

编辑

Tannaz Aliabadi-Oglesby

Lead Section Editor, BMJ Best Practice

利益声明

TAO declares that she has no competing interests.

Jo Haynes

Head of Editorial, BMJ Knowledge Centre

利益声明

JH declares that she has no competing interests.

Rachel Wheeler

Lead Section Editor, BMJ Best Practice

利益声明

RW declares that she has no competing interests.

Julie Costello

Comorbidities Editor, BMJ Best Practice

利益声明

JC declares that she has no competing interests.

Adam Mitchell

Drug Editor, BMJ Best Practice

利益声明

AM declares that he has no competing interests.

  • 成人脓毒症 images
  • 鉴别诊断

    • 全身炎症反应综合征 (systemic inflammatory response syndrome, SIRS) 的非感染性病因
    • 心肌梗死 (Myocardial infarction, MI)
    • 心包炎
    更多 鉴别诊断
  • 指南

    • 疑似脓毒症:识别、诊断和早期管理
    • 成人脓毒症指南实施建议
    更多 指南
  • 医学计算器

    格拉斯哥昏迷量表

    急性生理学与慢性健康状况评分系统 II (APACHE II)

    更多 医学计算器
  • Videos

    成人诊断性腰椎穿刺的动画演示

    气管插管的动画演示

    更多 操作视频
  • padlock-locked登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容

内容使用需遵循免责声明